← Back to Search

Infrared Imaging for Early Detection of Skin Cancer

Phase 1 & 2

Waitlist Available

Led By Sanchita krishna, PhD

Research Sponsored by Skinfrared LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Lesion less than 3.5 cm

All lesion in easily accessible places

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 years

Awards & highlights

Study Summary

This trial will test whether a new infrared imaging technology can detect melanoma and other skin cancers.

Who is the study for?

This trial is for individuals with skin lesions that are easily accessible and smaller than 3.5 cm, potentially indicating skin cancer. It's not suitable for minors or those with lesions near vital organs.Check my eligibility

What is being tested?

The study aims to test if a technique called functional dynamic infrared imaging can effectively screen for melanoma and other types of skin cancer.See study design

What are the potential side effects?

Since the intervention involves non-invasive infrared imaging, there are typically no side effects associated with this procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cancer lesion is smaller than 3.5 cm.

Select...

My cancer lesions are in places easy to reach.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To detect skin cancers with >90% sensitivity and >50% specificity using infrared imaging

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Skinfrared LLCLead Sponsor

Sanchita krishna, PhDPrincipal InvestigatorSkinfrared LLC

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT02154451 — Phase 1 & 2

Skin Cancer Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT02154451 — Phase 1 & 2

Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT02154451 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this clinical trial still open?

"According to clinicaltrials.gov, this medical trial has ceased recruitment and is no longer seeking patients; its initial posting was on August 1st 2013 with the last update seen being May 30th 2014. Thankfully, there are 160 alternative trials that still need enrolment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Transient Infrared Imaging for Early Detection of Skin Cancer

2013. "Transient Infrared Imaging for Early Detection of Skin Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02154451.

All > New Mexico > Skin Cancer